Anna Daily, PhD
Dr. Daily joined Ascendant Dx in January of 2011 after completing a post-doctoral research associate position in the Department of Chemistry and Biochemistry at the University of Arkansas. Daily’s main focus since joining the company has been leading the research and development of MelodyDx, a tear protein based assay for the detection of breast cancer. As such, she has played a key role in establishing clinical, industrial, and academic partnerships both locally and across the country. Dr. Daily provides expertise in the expression and purification of recombinant proteins, genetic engineering/cloning, as well as numerous biophysical and analytical chemistry techniques towards the characterization of proteins.